A 53-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2 inhibitor remains NYHA III without hypotension or hyperkalemia. Which add-on i...

Question

A 53-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2 inhibitor remains NYHA III without hypotension or hyperkalemia. Which add-on is reasonable to reduce HF hospitalization?

Accepted Answer

Vericiguat

Answer

High-dose loop diuretic chronically

Answer

Amlodipine

Answer

Diltiazem

Answer

Ivabradine at HR 58/min

us-abim MCQ (SBA): HFrEF Pharmacotherapy

A 53-year-old with HFrEF (EF 32%) on ARNI, beta-blocker, MRA, and SGLT2 inhibitor remains NYHA III without hypotension or hyperkalemia. Which add-on is reasonable to reduce HF hospitalization?